Top 15 Biotech Angel Investors in China in January 2026
A list of 15 angel investors that invest in Biotech startups based in China. We rank investors based on the number of investments they made in Biotech companies from China. We update this investor list every month.Top 15 Biotech Angel Investors in China in January 2026
| Investor | Biotech China investments |
|---|---|
| Jan Hammer | 4 |
| Bingqiang Gao | 2 |
| Woyong Fund | 1 |
| Huang Hao | 1 |
| Jason Zeng | 1 |
| Gong Hongjia | 1 |
| Mr. He Haichao | 1 |
| Mr. Fang Ying | 1 |
| Yahui Zhou | 1 |
| Ye Huahua | 1 |
| Mr. Zheng Xiaodong | 1 |
| Jiang Guangce | 1 |
| Suzhou Juming | 1 |
| Hua Guoping | 1 |
| Mr. Xie Youbang | 1 |
Jan Hammer is the partner at Index and the Board observer of Harmonic. Jan attended Oxford University.
Show more
Investment focus
- Health Care, Medical, Medical Device
- Series A, Series B, Seed
- China, United States, Czech Republic
Portfolio highlights
- Sofía — Improving the way millions of people take care of their health
- Transak — Transak offers a simple integration to allow your users to buy more than 100+ cryptocurrencies with credit/debit cards, or bank transfers in more than 120+ countries.
- Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
Bingqiang Gao is the Independent Non-Executive Director of Q Tech.
Show more
Investment focus
- Hardware, Robotics, Electronics
- Seed, Angel
- China, United States
Portfolio highlights
- Aiator — Aiator is an artificial intelligence product and technology solutions company focusing on industrial fields and biotechnology. Founded in 2010 by Silicon Valley Artificial Intelligence Scientist in Shenzhen Qianhai DreamWorks, the core members of the team are from the United States, the United Kingdom, Australia and Hong Kong. Currently, there arefour peacock talents and nearly 30 independent intellectual property rights. Weiai Intelligent is committed to carrying out AI empowerment services for enterprises, reducing costs and increasing efficiency.
- Shanmu SHANMU — Shanmu SHANMU is a micro medical robot specialist who uses self-developed digital microfluidic chipsets and artificial intelligence algorithms. The robot can continuously check the metabolic components in urine, establishing a link between the user's health status and disease and intelligently establishing multiple disease management cycles.
- LuMing Robotics — LuMing Robotics is a developer of intelligent robots. LuMing Robotics focuses on the field of embodied intelligent robots, and its business covers intelligent robot R&D and sales, artificial intelligence algorithm development, etc.
Woyong Fund is an individual investor.
Show more
Investment focus
- Medical, Biotechnology, Pharmaceutical
- Seed
- China
Portfolio highlights
- Boyin Bio — Boyin Bio is an innovative biomaterial research and development and application enterprise.
Huang Hao is the chairman of Yuanxu Fund.
Show more
Investment focus
- Medical, Biotechnology, Manufacturing
- Angel
- China
Portfolio highlights
- Yiweisen — Yiweisen is a research and development firm that manufactures functional natural compound raw materials.
Jason Zeng, one of the Core Founders and Advisor Emeritus of Tencent Group. Jason founded the Group in 1999. As the Chief Operating Officer during 1999 and 2007, Jason was responsible for overseeing the Company's business lines and product portfolios and the managing the Company’s sales and marketing activities across China. Prior toTencent, Jason worked in the Shenzhen Data Telecommunications Bureau and was familiar with the Internet and telecommunications industries in China. Since June 2007, Jason has been the Advisor Emeritus of the Company.
Show more
Investment focus
- Artificial Intelligence, Machine Learning, Social Media
- Seed, Angel, Series B
- United States, China
Portfolio highlights
- FangDD — FangDD is the an O2O real estate platform in China. It facilitates transactions between property sellers and home buyers through real estate brokers. FangDD works on a "pay-for-performance" business model instead of charging fees for every listings different from other domestic online estate services that charge customers for listingproperty information on the platforms, like SouFun and Anjuke.Currently, FangDD is in cooperation with over 100,000+ brokers, has offices in more than 30 cities and employs around 2500 people."In the first six months of this year(2014), Fangdd’s platform has seen more than 50 billion yuan ($8 billion) worth of real-estate transactions, and is aiming for 150 billion yuan worth of transactions for all of 2014" - Mr. Cao (Lightspeed China Partner).
- Hommily — Hommily is a new peer to peer social travel network helping connect travelers to locals from around the globe. Hommily makes it easy to connect with locals for tours, events, drivers, and activities during your trip.
- Locale — The Bay Area's best bakeries, restaurants and produce all in one delivery
Gong Hongjia is the the founder of Jiadao Capital.
Show more
Investment focus
- Audio, Music, Computer
- Angel, Seed, Series C
- China
Portfolio highlights
- KMAX — KMAX specializes in AR and VR content research and development. It has independently developed core technologies such as real-time 3D modeling, 3D generalized cloud connection, cloud VR resource rendering, and an editing engine.
- Lead Health — Lead Health is a hard technology startup company that transforms scientific and technological achievements of the academician team. It independently develops life science instruments and biopharmaceutical equipment and has independent intellectual property rights.
- CapitalBio Pharma — CapitalBio Pharma is a biotechnology company that specializes in innovative medicines to empower precise diagnosis and treatment. It is a subsidiary of CapitalBio Corporation.
Mr. He Haichao, Chairman of Jinwell Machinery and Chairman of Jinwell Fund
Show more
Investment focus
- Health Care, Biotechnology, Pharmaceutical
- Seed
- China
Portfolio highlights
- Sconray Biotech — Sconray Biotech is a green biotechnology company focusing on synthetic biology and green science. Their products include NAD+, 5-ALA, and diversified ones used in medicine, food, healthcare, daily chemicals, and agriculture.
Mr. Fang Ying, founding partner of Jinwell Fund.
Show more
Investment focus
- Health Care, Biotechnology, Pharmaceutical
- Seed
- China
Portfolio highlights
- Sconray Biotech — Sconray Biotech is a green biotechnology company focusing on synthetic biology and green science. Their products include NAD+, 5-ALA, and diversified ones used in medicine, food, healthcare, daily chemicals, and agriculture.
Zhou Yahui is the founder and Chairman of Kunlun. He previously worked at Thousand Oaks Group as a senior director and vice president. Zhou Yahui attended Tsinghua University.
Show more
Investment focus
- Software, Health Care, Biotechnology
- Series A
- China
Portfolio highlights
- NeoCura — NeoCura provides an AI platform to collect and analyze molecular biology data and clinical data, enabling physicians to make improve the diagnosis and treatment of cancer patients.
Ye Huahua is an Angel investor.
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Seed
- China
Portfolio highlights
- Ruier Weikang — Ruier Weikang focuses on the development and commercialization of brain scientific disease diagnostic, monitoring, and therapy products.
Mr. Zheng Xiaodong is the Chairman of Tofflon.
Show more
Investment focus
- Biotechnology, Medical, Hospital
- Series A, Series B
- China
Portfolio highlights
- St Phi Therapeutics — Yizun Biotechnology is a cutting-edge immune cell therapy company that has developed many unique platform technologies, including solid tumor treatment and allogeneic universal cell therapy.
- Hengyu Biotechnology — Hengyu Biotechnology is a CXO platform founded by a scientific research team that provides biosafety testing and related process validation.
Dr. Jiang Guangce is the chairman of Dechuan Medical Fund.
Show more
Investment focus
- Biopharma, Biotechnology, Pharmaceutical
- Seed
- China
Portfolio highlights
- Renjing Biology — Renjing Biotech is committed to the research and development of innovative drugs based on messenger ribonucleic acid (mRNA).
Suzhou Juming
Show more
Investment focus
- Biotechnology
- Series A
- China
Portfolio highlights
- Zion Pharma — Zion is a leading drug discovery platform that develops "me-better" drugs that address true unmet needs.
Hua Guoping is the the founder of Hualan Co.
Show more
Investment focus
- Biotechnology, Manufacturing, Health Diagnostics
- Series A
- China
Portfolio highlights
- Boyi Biotechnology — Boyi Biotechnology is a technology-based firm that provides vital raw materials and complete solutions to biomedical customers in the in vitro diagnostic market. It focus on diagnostic microspheres, testing raw materials, and quality control products.
Mr. Xie Youbang founding partner of Jinwell Fund.
Show more
Investment focus
- Health Care, Biotechnology, Pharmaceutical
- Seed
- China
Portfolio highlights
- Sconray Biotech — Sconray Biotech is a green biotechnology company focusing on synthetic biology and green science. Their products include NAD+, 5-ALA, and diversified ones used in medicine, food, healthcare, daily chemicals, and agriculture.
Investors by industry
Community
Artificial intelligence
Hardware
Marketplace
Consumer
FinTech
Energy
Gaming
Impact
Climate
Proptech
Google
Biotech
Health Care
EdTech
Sustainability
Venture Capital
Clean Energy
Art
Web3
Wellness
Android
Digital Media
Manufacturing
Construction
Organic Food
Sports
Franchise
eSports
Mobile
Enterprise Software
Big Data
Music
Email
Video Games
Social Media
Social Network
Publishing
Medical
Legal
B2B
Local
Food and Beverage
Internet
Biotechnology
Payments
Travel
Fitness
Recruiting
Hospitality
Mobile Advertising
Platforms
Cannabis
Real Estate
Automotive
Social
Wine And Spirits
Medical Device
Finance
Crowdfunding
CleanTech
Education
Mobile Apps
Transportation
InsurTech
Enterprise
Financial Services
Retail
LGBT
Infrastructure
Beauty
Photography
Renewable Energy
Oil and Gas
Fashion
Film
Life Science
Theatre
Non Profit
SaaS
Sporting Goods
Restaurants
Social Impact
Software
Celebrity
Agriculture (agtech)
Cryptocurrency
Machine Learning
Media (entertainment)
Facebook
Blockchain
Investors by country
New Zealand
Ireland
Canada
United States
India
Germany
United Kingdom
South Korea
Australia
Middle East
Indonesia
South Africa
Ghana
Egypt
Belarus
Hungary
Finland
Sri Lanka
France
Croatia
Gibraltar
Vietnam
Barbados
Georgia
Greece
Czech Republic
Faroe Islands
Costa Rica
Hong Kong
Bahrain
Belgium
Denmark
Europe
Bermuda
Estonia
Algeria
Ecuador
Bulgaria
Belize
Chile
Ethiopia
Liechtenstein
Panama
Myanmar
Lithuania
Malaysia
Peru
Liberia
Jersey
Lebanon
Norway
Mexico
Italy
Mali
Philippines
Israel
Kuwait
Mauritius
Malta
Morocco
Nicaragua
Togo
Rwanda
Slovenia
Poland
Uganda
San Marino
Sweden
Qatar
Serbia
Japan
Sierra Leone
Thailand
Tanzania
Uzbekistan
Zambia
Turkey
Uruguay
Tajikistan
Russian Federation
Portugal
El Salvador
Puerto Rico
Senegal
Zimbabwe
Tunisia
Venezuela
Ukraine
Singapore
Taiwan
Dominican Republic
Bahamas
Iraq
Iceland
Azerbaijan
Nigeria
Namibia
United Arab Emirates
Jamaica
Honduras
Isle of Man
Bolivia
Luxembourg
Pakistan
Albania
Spain
China
Romania
Jordan
Grenada
Argentina
Bangladesh
Armenia
Saudi Arabia
Oceania
Africa
LATAM
Kazakhstan
Kenya
Cayman Islands
Cambodia
Asia
Cyprus
Oman
Latvia
Brazil
Guatemala
Cameroon
Austria
Switzerland
Colombia
Seychelles
Marshall Islands
Angel Investors in China by industry
Retail
Financial Services
Payments
Food and Beverage
Wine And Spirits
B2B
Medical
Travel
Social Media
Manufacturing
Mobile
Software
Automotive
Biotechnology
FinTech
Real Estate
Enterprise
Health Care
Consumer
Energy
Biotech
EdTech
Sustainability
Climate
Proptech
SaaS
Marketplace
Community
Artificial intelligence
Hardware
Web3
Fashion
Photography
Education
Big Data
Blockchain
Gaming
Transportation
Cryptocurrency
Internet
Digital Media
Machine Learning
Media (entertainment)
Sports
Impact